Deletions of the homeobox gene SHOX (short stature homeobox) are an important cause of growth failure in children with short stature

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 3, 2002, Pages 1402-1406

  Rappold, Gudrun A ^a   Fukami, Maki ^a   Niesler, Beate ^a   Schiller, Simone ^a   Zumkeller, Walter ^b   Bettendorf, Markus ^a   Heinrich, Udo ^a   Vlachopapadoupoulou, Elpis ^c   Reinehr, Thomas ^d   Onigata, Kazumichi ^e   Ogata, Tsutomu ^f  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^c UNIVERSITY OF ATHENS   (Greece)

^d UNIVERSITY OF WITTEN HERDECKE   (Germany)

^e GUNMA UNIVERSITY   (Japan)

^f KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; CHILD; CONTROLLED STUDY; DYSCHONDROSTEOSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC CODE; GROWTH DISORDER; GROWTH HORMONE DEFICIENCY; HEARING IMPAIRMENT; HOMEOBOX; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; METACARPAL BONE; NONSENSE MUTATION; PALATE MALFORMATION; PREVALENCE; PRIORITY JOURNAL; SHORT STATURE; SHORT STATURE HOMEOBOX GENE; SINGLE STRAND CONFORMATION POLYMORPHISM; SKELETON MALFORMATION; TURNER SYNDROME; VALGUS DEFORMITY;

CUBITUS; VALGUS;

EID: 0036963699     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.3.8328     Document Type: Article

References (29)

1. Rao E, Weiss B, Fukami M, Rump A, Niesler B, Mertz A, Muroya K, Binder G, Kirsch S, Winkelmann M, Nordsiek G, Heinrich U, Breuning MH, Ranke MB, Rosenthal A, Ogata T, Rappold GA 1997 Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet 16:54-63
2. Ellison JW, Wardak Z, Young MF, Robey PG, Laig-Webster M, Chiong W 1997 PHOG, a candidate gene for involvement in the short stature of Turner syndrome. Hum Mol Genet 8:1341-1347
3. Belin V, Cusin V, Viot G, Girlich D, Toutain A, Moncla A, Vekemans M, Le Merrer M, Munnich A, Cormier-Daire V 1998 SHOX mutations in dyschondrosteosis (Leri-Weill syndrome). Nat Genet 19:67-69
4. Shears DJ, Vassal HJ, Goodman FR, Palmer RW, Reardon W, Superti-Furga A, Scambler PJ, Winter RM 1998 Mutation and deletion of the pseudoautosomal gene SHOX cause Léri-Weill dyschondrosteosis. Nat Genet 19:70-73
5. Spranger S, Schiller S, Jauch A, Wolff K, Rauterberg-Ruland I, Hager D, Tariverdian G, Troger J, Rappold G 1999 Leri-Weill syndrome as part of a contiguous gene syndrome at Xp22.3. Am J Med Genet 83:367-371
6. Cormier-Daire V, Belin V, Cusin V, Viot G, Girlich D, Toutain A, Moncla A, Vekemans M, Le Merrer M, Munnich A 1999 SHOX gene mutations and deletions in dyschondrosteosis or Leri-Weill syndrome. Acta Paediatr 88(Suppl):55-59
7. Kosho T, Muroya K, Nagai T, Fujimoto M, Yokoya S, Sakamoto H, Hirano T, Terasaki H, Ohashi H, Nishimura G, Sato S, Matsuo N, Ogata T 1999 Skeletal features and growth patterns in 14 patients with haploinsufficiency: SHOX: implications for the development of Turner syndrome. J Clin Endocrinol Metab 84:4613-4621
8. Stuppia L, Calabrese G, Borelli P, Gatta V, Morizio E, Mingarelli R, Di Gilio MC, Crino A, Giannotti A, Rappold GA, Palka G 1999 Loss of the SHOX gene associated with Leri-Weill dyschondrosteosis in a 45,X male. J Med Genet 36:711-713
9. Palka G, Stuppia L, Guanciali Franchi P, Chiarelli F, Fischetto R, Borrelli P, Giannotti A, Fioretti G, Renaldi MM, Mingarelli R, Rappold GA, Calabrese G 2000 Short arm rearrangements of sex chromosomes with haploinsufficiency of the SHOX gene are associated with Leri-Weill dyschondrosteosis. Clin Genet 57:449-453
10. Schiller S, Spranger S, Schechinger B, Fukami M, Merker S, Drop SL, Troger J, Knoblauch H, Kunze J, Seidel J, Rappold GA 2000 Phenotypic variation and genetic heterogeneity in Leri-Weill syndrome. Eur J Hum Genet 8:54-62
11. Grigelioniene G, Eklof O, Ivarsson SA, Westphal O, Neumeyer L, Kedra D, Dumanski J, Hagenas L 2000 Mutations in short stature homeobox containing gene (SHOX) in dyschondrosteosis but not in hypochondroplasia. Hum Genet 107:145-149
12. Huber C, Cusin V, Le Merrer M, Mathieu M, Sulmont V, Dagnoeau M, Munnich A, Cormier-Daire V 2001 SHOX point mutations in dyschondrosteosis. J Mol Genet 38:323
13. Clement-Jones M, Schiller S, Rao E, Blaschke RJ, Zuniga A, Zeller R, Robson SC, Binder G, Glass I, Strachan T, Lindsay S, Rappold GA 2000 The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome. Hum Mol Genet 9:695-702
14. Rosenfeld RG, Tesch LG, Rodriguez-Rigau LJ, McCauley E, Albertsson-Wikland K, Asch R, Cara J, Conte F, Hall JG, Lippe B, Nagel TC, Neely EK, Page DC, Ranke M, Saenger P, Watkins JM, Wilson DM 1996 Recommendation for diagnosis, treatment, and management of individuals with Turner syndrome. Endocrinologist 4:351-358
15. Binder G, Schwarze CP, Ranke MB 2000 Identification of short stature caused by SHOX defects and therapeutic effect of recombinant human growth hormone. J Clin Endocrinol Metab 85:245-249
16. Orita M, Suzuki Y, Skiya T, Hayashi K 1989 Rapid and sensitive detection of point mutations and polymorphisms using the polymerase chain reaction. Genomics 5:874-879
17. Lichter P, Cremer T 1992 Human genetics: a practical approach. Oxford, New York, Tokyo: IRL/Oxford University Press
18. Joly JS, Bourrat F, Nguyen V, Chourrout D 1997 Ol-Prx 3, a member of an additional class of homeobox genes, is unimodally expressed in several domains of the developing and adult central nervous system of the medaka (Oryzias latipes). Proc Natl Acad Sci USA 94:12987-12992
19. Blaschke RJ, Rappold GA 2000 SHOX: growth, Leri-Weill and Turner syndromes. Trends Endocrinol Metab 11:227-230
20. Shanske A, Ellison J, Vugui P, Dowling P, Wasserman E, Heinrich J, Saenger P 1999 Deletion of the pseudoautosomal region in a male with a unique Y;13 translocation and short stature. Am J Med Genet 82:34-39
21. Rappold GA 1993 The pseudoautosomal regions of the human sex chromosomes. Hum Genet 92:315-324
22. Ogata T, Matsuo N, Nishimura G 2001 SHOX haploinsufficiency and overdosage: impact of gonadal function status. J Med Genet 38:1-6
23. Carel JC, Mathivon L, Gendrel C, Ducret JP, Chaussain JL 1998 Near normalization of final height with adapted doses of growth hormone in Turner's syndrome. J Clin Endocrinol Metab 83:1462-1466
24. Donaldson MDC 1997 Growth hormone therapy in Turner syndrome: current uncertainties and future strategies. Horm Res 48(Suppl 5):35-44
25. Plotnick L, Attie KM, Blethen SL, Sy JP 1998 Growth hormone treatment of girls with Turner syndrome: the National Cooperative Growth Study experience. Pediatrics 102:479-481
26. Rosenfeld RG, Attie KM, Frane J, Brasel JA, Burstein S, Cara JF, Chernausek S, Gotlin RW, Kuntze J, Lippe BM, Mahoney CP, Moore WV, Saenger P, Johanson AJ 1998 Growth hormone therapy of Turner's syndrome: beneficial effect on adult height. J Pediatr 132:319-324
27. Sas TCJ, de Muinck Keizer-Schrama SMPF, Stejnen T, Jansen M, Otten BJ, Hoorweg-Nijman JJG, Vulsma T, Massa GG, Rouwe CW, Reeser HM, Gerver WJ, Gosen JJ, Rongen-Westerlaken C, Drop SLS 1999 Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: Results of a randomized dose-response trial. J Clin Endoctrinol Metab 84:4607-4612
28. Hintz RL, Attie KM, Baptista J, Roche A 1999 Effect of growth hormone treatment on adult height of children with idiopathic short stature. Genentech Collaborative Group. N Engl J Med 340:557-559
29. Flanagan S, Munns C, Williams B, Berry M, Hayes M, Vickers D, Rappold GA, Rao E, Hyland V, Batch J, Glass IA Heterogeneity for dyschondrosteosis-madelung deformity: differentiation of Léri Weill syndrome from other dyschondrosteoses. In press